These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35789061)

  • 1. COVID-19 pandemic and care of transfusion-dependent patients of thalassaemia: Experience from a paediatric centre in North India.
    Parakh N; Pahuja S; Singh V; Kumar N; Chandra J
    J Paediatr Child Health; 2022 Oct; 58(10):1760-1765. PubMed ID: 35789061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life in Transfusion-Dependent Thalassemia Patients in Greece Before and During the COVID-19 Pandemic.
    Klonizakis P; Klaassen RJ; Roy N; Papatsouma I; Mainou M; Christodoulou I; Tsapas A; Vlachaki E
    Value Health Reg Issues; 2024 Jul; 42():100986. PubMed ID: 38723367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of COVID-19 on transfusion-dependent thalassemia patients of Karachi, Pakistan: A single-center experience.
    Arshad Ali S; Azim D; Hassan HM; Iqbal A; Ahmed N; Kumar S; Nasim S
    Transfus Clin Biol; 2021 Feb; 28(1):60-67. PubMed ID: 33091482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and thalassaemia: A position statement of the Thalassaemia International Federation.
    Farmakis D; Giakoumis A; Cannon L; Angastiniotis M; Eleftheriou A
    Eur J Haematol; 2020 Oct; 105(4):378-386. PubMed ID: 32573838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore.
    Lam JCM; Lee SY; Koh PL; Fong SZ; Abdul-Kadir NI; Lim CY; Zhang X; Bhattacharyya R; Soh SY; Chan MY; Tan AM; Kuperan P; Ang AL
    Blood Cells Mol Dis; 2021 May; 88():102547. PubMed ID: 33607590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion practices during the COVID-19 pandemic: An experience from a hematology daycare in India.
    Senapati J; Aggarwal M; Louis L; Mirza SA; Kumar P; Dhawan R; Dass J; Vishwanathan GK; Pandey HC; Coshic P; Tyagi S; Seth T; Mahapatra M
    Transfus Apher Sci; 2021 Apr; 60(2):103025. PubMed ID: 33353804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood supply management amid COVID 19 pandemic: Challenges and strategies.
    Raghuwanshi B; Behera P; Singh P; Khan R; Munshi R; Patil A; Chouhan S
    J Family Med Prim Care; 2022 Jun; 11(6):2363-2368. PubMed ID: 36119265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 pandemic on rare diseases - A case study on thalassaemia patients in Bangladesh.
    Hossain MS; Runa F; Al Mosabbir A
    Public Health Pract (Oxf); 2021 Nov; 2():100150. PubMed ID: 34494010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD004450. PubMed ID: 23963793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the novel coronavirus disease and lockdown on the packed red blood cells inventory management: An experience from a tertiary care oncology center in Western India.
    Gupta AM; Ojha S; Nagaraju P; Poojary M; Sh S; Sathyan V; Ansari A
    Hematol Transfus Cell Ther; 2021; 43(2):126-132. PubMed ID: 33521581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Impact of the First Wave of COVID-19 and Associated Lockdown Restrictions on Persons with Disabilities in 14 States of India.
    Tetali S; Kamalakannan S; Sadanand S; Lewis MG; Varughese S; Hans A; Murthy GVS
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study.
    Alshamsi S; Hamidi S; Narci HO
    BMC Health Serv Res; 2022 Mar; 22(1):304. PubMed ID: 35248046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of COVID-19 pandemic on provision of sexual and reproductive health services in primary health facilities in Nigeria: a cross-sectional study.
    Adelekan B; Goldson E; Abubakar Z; Mueller U; Alayande A; Ojogun T; Ntoimo L; Williams B; Muhammed I; Okonofua F
    Reprod Health; 2021 Aug; 18(1):166. PubMed ID: 34348757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of cardiac iron overload by optimising iron chelation therapy in transfusion dependent thalassaemia using cardiac T2* MRI: a quality improvement project from Pakistan.
    Hussain S; Hoodbhoy Z; Ali F; Hasan E; Alvi N; Hussain A; Ishrat K; Ur Rahman Z; Qamruddin A; Parvin A; Hasan BS
    Arch Dis Child; 2020 Nov; 105(11):1041-1048. PubMed ID: 32994214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.
    Taher AT; Radwan A; Viprakasit V
    Vox Sang; 2015 Jan; 108(1):1-10. PubMed ID: 25286743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the COVID-19 pandemic on the continuity of transfusion care for thallasemic patients: a case report.
    Bouhou S; Benajiba M; Masrar A
    Pan Afr Med J; 2021; 38():33. PubMed ID: 33777301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 pandemic and blood transfusion services: The impact, response and preparedness experience of a tertiary care blood center in southern Karnataka, India.
    Kandasamy D; Shastry S; Chenna D; Mohan G
    Hematol Transfus Cell Ther; 2022; 44(1):17-25. PubMed ID: 34931179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Pandemic and Thalassemia Major Patients: Transfusion Practice and Treatment Assessment.
    Oymak Y; Karapinar TH
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1073-e1076. PubMed ID: 33273415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry.
    El-Battrawy I; Longo F; Núñez Gil IJ; Abumayyaleh M; Gianesin B; Estrada V; Aparisi Á; Arroyo-Espliguero R; Balocco M; Barella S; Beccaria A; Bonetti F; Casale M; De Michele E; Denotti AR; Fidone C; Fortini M; Gamberini MR; Graziadei G; Lisi R; Massa A; Marcon A; Rubinski B; Miano M; Motta I; Pinto VM; Piperno A; Mariani R; Putti MC; Quota A; Ribersani M; Marziali M; Roberti D; Rosso R; Tartaglione I; Vitucci A; Voi V; Zecca M; Romero R; Marouneld C; Fernández-Rozas I; Espejo C; Marhaeni W; Garcia Aguado M; Cappellini MD; Perrotta S; De Franceschi L; Piga A; Forni GL; Akin I
    J Cell Mol Med; 2022 May; 26(9):2520-2528. PubMed ID: 35355397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current challenges of blood transfusions in patients with thalassemia in India and future perspectives.
    Datta SS; Sinha A
    Transfus Clin Biol; 2024 Aug; 31(3):162-166. PubMed ID: 38513824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.